# Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients

> **NCT06681662** · PHASE4 · RECRUITING · sponsor: **Matias Vested** · enrollment: 80 (estimated)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Ephedrine Hydrochloride 30 mg/ml
- **DRUG:** Saline (NaCl 0,9 %) (placebo)

## Key facts

- **NCT ID:** NCT06681662
- **Lead sponsor:** Matias Vested
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681662, "Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06681662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*